^
    3ms
    X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma (clinicaltrials.gov)
    P1, N=12, Recruiting, Immunolight, LLC | Trial completion date: Feb 2025 --> Aug 2025 | Trial primary completion date: Mar 2024 --> Sep 2024
    Trial completion date • Trial primary completion date • Metastases
    |
    methoxsalen (X-PACT)
    11ms
    X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma (clinicaltrials.gov)
    P1, N=12, Recruiting, Immunolight, LLC | Trial primary completion date: Mar 2023 --> Mar 2024
    Trial primary completion date • Metastases
    |
    methoxsalen (X-PACT)